Glenmark Pharmaceuticals is enhancing its capabilities in translational research by opening a new discovery center at the Biopôle campus in Lausanne.   Glenmark will continue to invest in, and operate its process development and biologics manufacturing center out of La-Chaux-de-Fonds, Neuchȃtel. Approximately 20% of current employees will be housed in the discovery group at Lausanne.   “The Biopôle is one of the most vibrant ecosystems for life sciences innovation in Europe...